Incyte (INCY) Reports Q1 Loss of $2.86, Reaffirms Guidance
Get Alerts INCY Hot Sheet
Revenue Growth %: +15.2%
Financial Fact:
Selling, general and administrative: 75.78M
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
Incyte (NASDAQ: INCY) reported Q1 EPS of ($2.86), versus $0.62 reported last year. Revenue for the quarter came in at $568.5 million versus the consensus estimate of $556.04 million.
2020 Financial Guidance:
The Company has reaffirmed its full year 2020 financial guidance, as detailed below. The R&D expense guidance now includes the expenses related to Incyte’s share of tafasitamab development costs under the MorphoSys collaboration, but excludes $805 million of upfront consideration paid under the MorphoSys collaboration. The financial guidance also excludes the impact of any potential future strategic transactions.
All data in millions |
| Current |
| Previous |
Jakafi net product revenues |
| $1,880 - $1,950 |
| Unchanged |
Iclusig net product revenues |
| $100 - $105 |
| Unchanged |
GAAP Cost of product revenues |
| $130 - $135 |
| Unchanged |
Non-GAAP Cost of product revenues1 |
| $107 - $112 |
| Unchanged |
GAAP Research and development expenses |
| $1,210 - $1,280 |
| Unchanged |
Non-GAAP Research and development expenses2 |
| $1,079 - $1,149 |
| Unchanged |
GAAP Selling, general and administrative expenses |
| $505 - $535 |
| Unchanged |
Non-GAAP Selling, general and administrative expenses2 |
| $447 - $477 |
| Unchanged |
GAAP Change in fair value of acquisition-related contingent consideration |
| $25 - $27 |
| Unchanged |
Non-GAAP Change in fair value of acquisition-related contingent consideration3 |
| $0 |
| Unchanged |
For earnings history and earnings-related data on Incyte (INCY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lockheed Martin (LMT) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY24 Guidance
- Option Care Health (OPCH) Tops Q1 EPS by 3c, provides guidance
- NVR, Inc. (NVR) Tops Q1 EPS by 1244c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!